SYRE - Spyre Therapeutics Inc

-

$undefined

N/A

(N/A)

Spyre Therapeutics Inc NASDAQ:SYRE Combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. On Nov. 27, 2023, company announced its name change to Spyre Therapeutics, Inc. Effective as of market open on November 28, 2023, Spyre will trade on Nasdaq under the ticker symbol "SYRE".

Location: | Website: spyre.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

404.4M

Cash

603.1M

Avg Qtr Burn

-39.35M

Short % of Float

25.20%

Insider Ownership

8.72%

Institutional Own.

-

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.